Two similar genes, dnmL and rmbA in Streptomyces peucetius, which encode for glucose-1-phosphate (G-1-P) thymidylyltransferases were expressed in Escherichia coli under similar conditions. While RmbA was expressed in soluble form, DnmL was found as insoluble aggregates in inclusion bodies. The difference in expression of these similar proteins led to investigate into the amino acid sequences of these proteins by sequence alignment, hydrophobicity scale and homology modeling. These analyses showed that the two proteins are different only in the C-terminal sequences. Deletion of C-terminal sequence of DnmL increased the expression level of truncated DnmL. Substitution of C-terminal sequence of DnmL with RmbA also expressed the recombinant protein in soluble form. Finally, mutation of six amino acids in DnmL rendered the protein expressed in soluble form. These results suggested that the soluble expression of the thymidylyltransferases lies in the C-terminal sequences. In conclusion, these methods of protein engineering will be a rational tool for enhancing solubility of proteins expressed in E.coli.
Introduction
Escherichia coli is frequently used for the production of recombinant proteins due to its rapid growth, low cost of culturing and well-known genetics. However, these proteins are often found as insoluble aggregates in inclusion bodies. These aggregated proteins are, in general, misfolded and thus required to be solubilized and refolded to the functional proteins for biochemical analysis, structural studies or therapeutic uses. Refolding from inclusion bodies into bioactive protein is, however, undesirable because the process requires many operational steps and the recovery of refolded protein is very low. Common strategies for enhancing the production of soluble proteins are to optimize expression conditions by varying isopropylthio-b-D-galactosidase (IPTG) concentrations, pH conditions, temperature and growth media (Makrides, 1996; Baneyx, 1999; Schumann and Ferreira, 2004) . But, active soluble forms of the proteins are not obtained in all cases. Alternatively, the solubility of proteins can also be improved by co-expression with solubility fusion tags (Davis et al., 1999) or molecular chaperones (Tresaugues et al., 2004) . But, not all tags and chaperones are efficient for promoting proper folding of the fused proteins.
The amino acid sequence determines the folding pathways of a protein as it moves toward its native structure (Lins and Brasseur, 1995) . During protein folding, the hydrophobic residues are buried in the interior of the protein while intraand intermolecular hydrogen bonds formed by polar side chains contribute to protein stability (Kyte and Doolittle, 1982) . Although the importance of hydrogen bonding is always clear, the hydrophobic effect is the dominant force in protein folding (Dill, 1990; Pace et al., 1996) . Thus, predicting hydrophobic regions in proteins can help in understanding protein folding and hence determining protein structures. A simple method for achieving this goal is to use sequence alignment analysis to investigate amino acid differences between similar protein sequences. In this method, a number of amino acids that tend to alter thermodynamic stability or solubility of the protein are selected to mutate (Waldo, 2003; Eijsink et al., 2005) , and these substitutions rarely affect protein structure or function. Another advantage of this approach is that the knowledge of the 3D structure of the protein of interest is not essential. If the 3D structure of protein is known, it is possible to alter the solubility by mutagenesis (Dale et al., 1994) .
Streptomyces peucetius ATCC 27952, a soil dwelling bacteria, is a potent producer of the antitumor antibiotics, daunorubicin and doxorubicin. These antibiotics harbor a 2,3,6-trideoxy-3-aminohexose, L-daunosamine that confers antitumor as well as antibacterial activity to these antibiotics. The L-daunosamine is incorporated into rhodomycinone as an activated sugar TDP-L-daunosamine to form rhodomycin D which undergoes several modifications to generate doxorubicin (Fig. 1) . The precursor of TDP-L-daunosamine is TDP-D-glucose which is formed from glucose-1-phosphate (G-1-P) and thymidine triphosphate (dTTP) by the action of G-1-P thymidylyltransferase. Initially, G-1-P thymidylyltransferase gene dnmL from doxorubicin gene cluster was believed to be involved in the biosynthesis of TDP-D-glucose. But, expression of additional copies of dnmL in S.peucetius did not enhance the conversion of rhodomycinone to daunorubicin (Gallo et al., 1996) . Similarly, when dnmL was expressed in the S.peucetius recombinant strain, the conversion of rhodomycinone to rhodomycin D was apparently low (Olano et al., 1999) . It was implied that the reason for lower efficiency of S.peucetius recombinant strain to produce rhodomycin D was likely due to lower expression of dnmL than its intrinsic activity.
So far, various thymidylyltransferases have been shown to utilize a wide variety of sugar-1-phosphates and nucleoside triphosphates demonstrating the synthetic utility of these biocatalysts (Timmons et al., 2007; Jakeman et al., 2008) . Although several thymidylyltransferases have been exploited to prepare different sugar nucleotides by active site engineering (Barton et al., 2002; Moretti and Thorson, 2007; Moretti et al., 2011) , there have been no previous reports of converting the inactive and insoluble inclusion bodies of thymidylyltransferases into active soluble form by enzyme engineering. Besides, the lengths of these thymidylyltransferases vary from strain to strain depending upon the metabolic pathways in which they participate. In contrast with known thymidylyltransferase, RmlA (293 aa) from E.coli, the protein encoded by ST0452 (a RmlA homolog) has an additional 170-residue C-terminal domain. To determine the function of this domain, a truncated protein of ST0452 was designed and expressed in E.coli. This truncated enzyme was expressed in soluble form but it did not possess the complete RmlA activity exhibited by the full-length enzyme. Further experiments exhibited that the additional C-terminal domain of ST0452 plays an important role in both the thermostability and thymidylyltransferase activity of this enzyme (Zhang et al., 2005) .
In this study, we expressed dnmL in E.coli to study the enzymatic activity of DnmL protein. But, DnmL was mainly found in inclusion bodies hindering the in vitro study of the enzyme. Coincidentally, we found another G-1-P thymidylyltransferase gene rmbA in S.peucetius genome. The recombinant enzyme RmbA was expressed in soluble form under the similar condition for the expression of DnmL. Thorough analysis by sequence alignment, hydrophobicity graphing and 3D modeling, it was found that the two proteins were different from each other at their C-terminal sequence only. Deletion, substitution and mutation in the C-terminal sequence of DnmL revealed that the C-terminal sequence of the thymidylyltransferase determines the solubility of the protein when expressed in E.coli.
Materials and methods
Bacterial strains, plasmids, media and culture conditions All E.coli strains and plasmids used in this study are listed in Table I . The E.coli XL1-Blue MRF 0 (Stratagene) and E.coli BL21(DE3) (Novagen) strains were used as hosts for gene cloning and protein expression, respectively. The E.coli strains were grown in Luria Bertani (LB) liquid or solid agar media supplemented with ampicillin (100 mg ml 21 ) at 378C incubator. The pGEM w -T Easy (Promega) and pET-32a(þ)(Novagen) vectors were used for cloning and expression, respectively. The pGEM w -3Zf(þ)(Promega) and pUC118 (TaKaRa) vectors were used for sub-cloning.
DNA manipulation
DNA amplification, isolation, digestion and ligation were performed by following standard techniques for E.coli (Sambrook and Russell, 2001) and Streptomyces (Kieser et al., 2000) . The enzymes and chemicals used in this study were purchased from TaKaRa and Sigma, respectively. In silico analysis and comparison of nucleotide and protein sequences were performed by the use of the programs BLAST, CLUSTALW, GENEDOC, FASTA, MODELLER and Accelrys Discovery Studio.
Construction of recombinant vectors
All primers used in this study are listed in Table II . A pair of primers, dnrL-F/dnrL-B and NGS-F1/NGS-B2, was used to amplify dnmL (1068 bp) and rmbA (1068 bp), respectively, from S.peucetius. Polymerase chain reaction (PCR) was performed in a Thermal Cycler Dice (TaKaRa, Japan). The PCR products were purified and cloned separately in pGEM w -T Easy vector for DNA amplification and sequencing. The clone products of dnmL and rmbA in pGEM w -T Easy vector were excised by BamHI -EcoRI and BamHIHindIII, respectively, to clone into pET-32a(þ) separately to construct pDL32 and pRA32, respectively. A pair of primers, dnrL-F/dnmL-B, was used to amplify the C-terminal deleted dnmL (810 bp). A new TCA codon was introduced when designing the dnmL-B primer to terminate the expression of protein. The truncated dnmL cloned into pGEM w -T Easy vector was excised by BamHI-EcoRI and ligated into pET-32a(þ) to construct pDN32. A pair of primers, rmb-F1/ NGS-B2, was used to amplify the C-terminal region of rmbA (258 bp) to be connected with the N-terminal region of dnmL. To substitute the C-terminal residues of dnmL with those of rmbA, dnmL cloned into pGEM w -T Easy vector was excised by BamHI-PstI to insert into pGEM w -3Zf(þ) vector to create pDL3. The plasmid pDL3 was cut with ApaI-HindIII to insert the PCR product of the C-terminal region of rmbA to create pDR3. Finally, the recombinant dnmL -rmbA was cut by BamHI-HindIII from pDR3 and ligated into pET-32a(þ) to create pDR32. Synthetic nucleotides (264 bp) to create six-point mutations in the C-terminal region of dnmL were synthesized and ligated into pUC118 vector to create pCD4. The clone products of dnmL in pGEM w -T Easy vector were excised by BamHI-ApaI and cloned into pCD4 to generate pMD5. Finally, the mutated dnmL insert was excised by BamHI -HindIII and cloned into pET-32a(þ) to construct pMD32.
Expression and purification of recombinant proteins
The recombinant vectors, pDL32, pRA32, pDN32, pDR32 and pMD32, were individually transformed into E.coli BL21(DE3) to construct various recombinant strains as shown in Table I . The expression vector pET-32a(þ) was also transformed into E.coli BL21(DE3) for control experiment. The recombinant E.coli strains were grown in 3 ml LB culture medium. The overnight cultures were transferred to 50 ml fresh LB/Sorbitol medium. When cell density was 0.6 at OD 600 , gene expression was induced by addition of IPTG to a final concentration of 0.4 mM and the incubation was continued at 208C for 20 h. The cell pellets were harvested by centrifugation at 6000 Â g for 10 min and washed twice with 15 ml of 50 mM Tris-HCl buffer ( pH 7.2) containing 10% glycerol. Finally, the cell pellets were re-constituted in 2 ml of equilibration buffer containing 1 mM phenylmethanesulphonylfluoride, 1 mM EDTA ( pH 8) and 50 mM Tris-HCl buffer ( pH 7.2) containing 10% glycerol. The cells were lysed by an ultra-sonicator. The crude soluble proteins were collected after removing cell debris by centrifugation at 12 000 Â g for 30 min at 48C.
All the proteins under study were expressed as recombinant proteins with poly-His tag fused to their N-terminus prior to purification. Expressed His-tagged proteins were purified by cobalt-immobilized affinity chromatography using TALON resin (Clontech) according to the manufacturer's instructions. After elution with 200 mM imidazole from the resin column, the proteins were dialyzed overnight to obtain purified proteins. The proteins were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS -PAGE) on a 12% (w/v) polyacrylamide gel. Molecular weight of the enzyme was determined by comparison with 
Soluble expression of G-1-P thymidylyltransferases in E.coli standard molecular weight protein marker (Novagen). Protein concentration was estimated by the Bradford method (Bio-Rad protein assay kit) using bovine serum albumin as the standard.
Enzyme assay and HPLC analysis
Enzyme assays for thymidylyltransferases were performed using 0.5-5 mM dTTPs, 10-40 mM G-1-P, 1 mM MgCl 2 .6H 2 O, 1 mM dithiothreitol, 1.8 U inorganic pyrophosphatase, 50 mM Tris-HCl ( pH 7.2) and 0.2-5 mM G-1-P thymidylyltransferase. Enzyme kinetics were obtained by fixing G-1-P at a saturating concentration of 40 mM and varying the concentration of dTTP. The reaction was carried out for 5-90 min at 378C. The enzyme reaction was quenched by heating the reaction mixture at 908C for 5 min, followed by centrifugation for 5 min. The supernatant thus obtained was analyzed by high-performance liquid chromatography (HPLC) using Hypersil BDS C8 column (250 Â 4.6 mm 5 mm, Thermo) with an isocratic elution system of 100 mM potassium phosphate buffer ( pH 7.0) containing 8 mM tetra-n-butyl ammonium hydrogen sulfate and methanol (95:5, v/v) at a flow rate of 1 ml min 21 for 30 min. Peaks were detected using a UV absorbance detector monitoring at 254 nm. Authentic TDP-D-glucose was used as a reference.
Results

Expression of dnmL as inclusion bodies in E.coli
The G-1-P thymidylyltransferase gene dnmL was expressed in E.coli BL21(DE3) and DnmL protein was extracted from E.coli as described in Materials and methods. Over-expression of this G-1-P thymidylyltransferase resulted in the production of inclusion bodies and very negligible amount of soluble protein of DnmL was observed in SDS-PAGE (Fig. 2) . The inclusion bodies are usually formed due to high concentration of the over-expressed protein. Therefore, the formation of inclusion bodies can be reduced by controlling the rate of protein synthesis in E.coli. To enhance the production of soluble protein of DnmL, IPTG concentration was varied from 0.1 to 1.0 mM of concentration during induction period. Although the expression level of protein changed with varied concentration of IPTG, soluble protein of DnmL was not obtained. Neither changing pH of the culture media from 6 to 8 enhanced the solubility of the expressed protein, nor did varying temperature conditions of the cultures improve the solubility of DnmL. Besides, the expression vector, pET-32a(þ) was replaced by pET-28a(þ) and E.coli BL21(DE3)pLysS was used as host instead (data not shown). None of these attempts enhanced the solubility of the expressed DnmL protein.
Expression of rmbA as soluble protein in E.coli Homology searches of S.peucetius genome with the BLAST program revealed another putative G-1-P thymidylyltransferase gene rmbA which is homolog to dnmL (69% identity, 86% similarity). The rmbA gene was found within the rhamnose gene cluster (Singh et al., 2010) . The rmbA was expressed in soluble protein in E.coli under normal condition of overexpression. The cell free extracts showed 56 kDa band of soluble RmbA in the SDS -PAGE (Fig. 2) .
Hydrophobicity of DnmL and RmbA
Hydrophobicity plot is designed to display the distribution of polar and non-polar residues along a protein sequence. The hydrophobicity of the amino acids in the polypeptide backbone of DnmL and RmbA was examined on Kyte -Doolittle hydrophobicity scale by using Hydrophobicity Grapher from http://athena.bioc.uvic.ca/ (Kyte and Doolittle, 1982; Hopp and Woods, 1983; Parker et al., 1986) . The hydrophobicity plot showed a similar pattern of hydrophobicity along the DnmL and RmbA sequences. However, a marked difference in hydrophobicity was found in the C-terminal region of these proteins (Fig. 3) . The overall hydrophobicity of the last 50 aa in RmbA protein sequences was higher as compared with that of DnmL sequence. Therefore, it was assumed that the soluble expression of the thymidylyltransferases would rely on the C-terminal sequence of these proteins.
Construction and expression of truncated dnmL in E.coli G-1-P thymidylyltransferases contains a dTTP-binding domain (   8   GGXGTR   13 ) and a TDP-D-glucose-binding site ( 157 EKP 159 ) in their N-terminal regions (Blankenfeldt et al., 2000; Zuccotti et al., 2001) . These active sites for binding substrate and product are conserved in DnmL sequences. Besides, DnmL (355 aa) had longer protein sequences than the well-known G-1-P thymidylyltransferases (,296 aa) ( Supplementary Fig. S1 ). Assuming the active sites located in N-terminal region of DnmL were functional, a truncated DnmL protein was designed by deleting 87 amino acids residing in the C-terminus of DnmL. For this, a TGA stop codon was inserted after the 807th nucleotide sequence of dnmL. When the truncated dnmL was expressed in E.coli, the protein ( 48 kDa) was expressed in soluble form (Fig. 2) while the full length of dnmL was not expressed in soluble form in similar condition.
Construction and expression of fused dnmL -rmbA in E.coli
A fusion protein of N-terminal of DnmL with C-terminal of RmbA was designed in which the 84 amino acids residing in the C-terminal of DnmL would be substituted by the same number of residues from the C-terminal of RmbA. To construct the fusion dnmL-rmbA, N-terminal sequence of dnmL (811 bp) was fused with C-terminal sequence of rmbA (251 bp) as described in Materials and methods. When the fused dnmL-rmbA was expressed in E.coli, the fusion protein DnmL -RmbA was readily expressed in soluble form (Fig. 2) . The level of expression of DnmL -RmbA was quite similar to the expression level of RmbA.
Homology modeling of DnmL and RmbA
To know the 3D conformation of the C-terminal sequence of DnmL and RmbA, homology modeling of these proteins was constructed using MODELLER (http://salilab.org/modeller/ modeller.html). A model template 1H5R of E.coli G-1-P thymidylyltransferase (Zuccotti et al., 2001 ) from Protein Data Bank (PDB) was chosen because DnmL and RmbA share similar overall sequence identity with the template. The model template 1H5R coincided with different G-1-P thymidylyltransferases, 1FXO (Blankenfeldt et al., 2000) and 1MC3 (Sivaraman et al., 2002) from PDB when superimposed ( Supplementary Fig. S2 ). Similarly, when the 3D model of DnmL was superimposed with 1H5R to identify similarities of protein folds, the proteins had similar structures at their N-terminal region and coincided to a great extent ( Supplementary Fig. S3 ). Since the DnmL had longer sequences than 1H5R, the extended sequences of C-terminal region of DnmL formed loop structure without any folds. But, when 3D structures of DnmL and RmbA were compared, almost all of the structures superimposed with each other except for the C-terminal regions (Fig. 4) . While the C-terminus of DnmL had a long loop structure, the C-terminus of RmbA had two helices instead.
Structural alignment attempts to establish homology between two protein tertiary structures based on their shape and 3D conformation. Therefore, the structures of DnmL and RmbA were aligned using Accelrys Discovery Studio (Fig. 5) . The program revealed that N-terminal part of both proteins contained similar amino acid residues with similar structures but the amino acid residues in the C-terminal part of these proteins had different structures. The two amino acid sequences ( 314 ITGVRRVEASL 324 ) and ( 340 AHRLVLGDHS 349 ) at the C-terminus of RmbA rendered two helical structures to RmbA whereas similar sequences Structural analysis of the homology model of RmbA demonstrated that the helical structures of the RmbA were due to several hydrogen bonds between the particular amino acids located in the C-terminal region (Fig. 6) -H 348 were found to hold the integrity of the helical structures in RmbA. These interactions were unavailable at the C-terminal structure of DnmL due to different amino acids existing at the corresponding sites.
Construction and expression of mutated dnmL in E.coli
Thorough analysis of C-terminal sequence and homolog structure of DnmL and RmbA, six amino acids (313R, 317T, 322H, 339A, 341S and 348D) in the C-terminal of DnmL were quite different from the amino acids (313S, 317V, 322A, 339S, 341H and 348H) located at the corresponding position in RmbA. It was quite interesting to find that those amino acids in RmbA were also conserved in other bacterial thymidylyltransferases (Fig. 7) . Substitution of these amino acids (R313S, T317V, H322A, A339S, S341H and D348H) in DnmL gave rise to highly similar hydrophobicity pattern with RmbA ( Supplementary Fig. S4 ). Similarly, when 3D structure of mutated DnmL was designed, it had similar helical structures at C-terminus that resembled with RmbA structure. Therefore, an oligonucleotide sequence (254 bp) was designed to mutate the particular amino acids (R313S, T317V, H322A, A339S, S341H and D348H) in the DnmL sequence ( Supplementary Fig. S5 ). The synthetic oligonucleotide was joined with the N-terminal of dnmL to form a full length of mutated dnmL as described in Materials and methods. When the mutated dnmL was expressed in E.coli, the expressed protein was found to be soluble. The level of expression of mutated DnmL was similar to the level of expression of RmbA in similar condition.
Enzyme activity of G-1-P thymidylyltransferases
To test the catalytic activity of RmbA, an enzyme assay of RmbA was carried out using G-1-P and dTTP as described in Materials and methods. The enzyme products were analyzed by HPLC. A peak corresponding to TDP-D-glucose was detected on HPLC chromatogram and the product was further confirmed by ESI mass analysis. The formation of TDP-glucose was calculated as a percentage of dTTP converted to TDP-glucose. The catalytic efficiency of RmbA was shown in Table III . The concentration of dTTP did not change in a control reaction without RmbA. When the enzyme activity of truncated DnmL was tested in a way similar to RmbA reaction, no thymidylyltransferase activity of truncated DnmL was observed. The catalytic activity of fused DnmL -RmbA and mutated DnmL was similar (Table III) . 
Discussion
Streptomyces peucetius harbors two G-1-P thymidylyltransferase genes, dnmL (GenBank accession no. GQ169534) and rmbA (GenBank accession no. FJ976891) in its genome. While dnmL is located in the biosynthetic gene cluster of doxorubicin, rmbA was found within the rhamnose biosynthetic gene cluster at another locus in the genome. While dnmL participates in the formation of secondary metabolite, rmbA plays a role in the biosynthesis of primary metabolites. The genes for primary metabolism are expressed from the initial stage of cell growth whereas the genes for secondary metabolite production are usually expressed at late exponential phase. Under normal condition, a well-known G-1-P thymidylyltransferase, rmlA (a rmbA homolog from Salmonella enterica) was easily expressed into soluble protein in E.coli (Moretti and Thorson, 2007) . RmlA catalyzes the first reaction of the biosynthesis of L-rhamnose, a key component of many bacterial polysaccharides. But, the overexpression of sgcA1 (a dnmL homolog from Streptomyces globisporus) in E.coli resulted in an overproduction of SgcA1 in insoluble form (Murrell et al., 2004) . SgcA1 participates in the biosynthesis of enediyne antitumor antibiotic C-1027. It seemed that the genes participating in the biosynthesis of secondary metabolites production are not easily expressed in soluble forms in E.coli. Moreover, thymidylyltransferases involved in secondary metabolism have, in general, been reported to be more substrate stringent than the thymidylyltransferases from primary metabolism (Murrell et al., 2004; Kudo et al., 2005) .
Owing to the above reasons, we initiated the expression of dnmL in E.coli to study the enzymatic activity of DnmL protein. But, the formation of inclusion bodies hindered in vitro experiments. Similar problem occurred during the overexpression of sgcA1 (glucopyranosyl-1-phosphate thymidylyltransferase) in E.coli which resulted in an overproduction of SgcA1 but in almost completely insoluble form (Murrell et al., 2004) . By lowering the fermentation temperature and increasing the incubation time, solubility of the overproduced SgcA1 was improved by 5% only. In our study also, several strategies such as concentration of IPTG for induction, pH of the medium, temperature and growth conditions were used to reduce inclusion bodies. Despite all efforts, we did not obtain soluble DnmL protein enough for further experiments. Meanwhile, a dnmL homolog gene rmbA was expressed in E.coli by the same method to express dnmL, RmbA protein was readily obtained in soluble form. Although DnmL and RmbA have exactly the 355 aa in their sequence, it was surprising when the expression pattern of the two homolog proteins were dissimilar. When enzyme assay was carried out, RmbA had G-1-P thymidylyltransferase activity. These consequences increased our interest in understanding of solubility of the proteins.
Initially, we calculated the hydrophobicity of the protein sequences of DnmL and RmbA by hydrophobicity plot because hydrophobicity patterning along the sequence predicts the folding mechanism and aggregation of proteins (Zbilut et al., 2004) . The hydrophobicity plot showed similar hydrophobicity along the amino acid sequence of these proteins but the C-terminal sequence of RmbA had higher hydrophobicity as compared with DnmL. Therefore, it is likely that the soluble expression of RmbA is contributed to high hydrophobicity of C-terminal peptide sequence. Since hydrophobic interaction is a major driving force in the protein folding, it was assumed that the hydrophobic residues in the C-terminal of RmbA would be responsible for proper folding and hence its expression in soluble form.
Inclusion bodies are formed from partially folded protein intermediates which aggregate through non-covalent interactions (Bowden et al., 1991; Przybycien et al., 1994) . Besides, the N-terminal and C-terminal residues of proteins can greatly affect expression yield and solubility (Klock et al., 2008) . As DnmL had longer protein sequence at the C-terminal than the known G-1-P thymidylyltransferases, we designed a truncated DnmL by deleting 87 amino acids residing in the C-terminal region. Interestingly, the truncated DnmL was highly expressed in soluble form in E.coli. Deletion of the C-terminal part in DnmL might have removed improper folding structure to generate an intermediate protein that was free from strong non-covalent interactions and hence the truncated protein was expressed in soluble form. Although the level of expression of truncated DnmL was higher than the soluble expression of RmbA, the truncated DnmL did not display thymidylyltransferase activity. The experiments demonstrated that the C-terminal residues of DnmL hindered protein solubility but they were indispensable for enzyme activity.
Later, we hypothesized that substitution of the C-terminal sequence of DnmL with the C-terminal sequence of RmbA would enhance the solubility of the expressed DnmL. Hence, we replaced the C-terminal sequence of DnmL with the a Kinetics were performed with 0.2-5 mM G-1-P thymidylyltransferase, 0.5-5 mM dTTP, 1 mM DTT, 1 mM MgCl 2 , 1.8 U inorganic pyrophosphatase and fixed 40 mM G-1-P at saturating concentration in 50 mM Tris-HCl (pH 7.2) at 378C, and conversion was detected by HPLC.
same number of amino acids from RmbA protein.
Interestingly, the new recombinant protein, DnmL -RmbA, was expressed in soluble form under normal condition. The level of expression and enzymatic activity of DnmL -RmbA were similar to that of RmbA. The result showed that the active sites intact in N-terminal residues of DnmL were functional. Moreover, the C-terminal residues of these thymidylyltransferases had a significant role in determining the protein solubility and activity. Structure-based sequence alignments are more accurate than normal sequence alignments. Structure alignments are used to align, analyze and annotate structural features in integrated sequence and structure multiple alignments. Therefore, 3D structures of DnmL and RmbA proteins were designed by MODELLER. When the homology models of DnmL and RmbA proteins were superimposed with each other, the 3D structures of both proteins coincided with each other except in the C-terminal region. While the C-terminal of DnmL possessed loop-like structure, the C-terminal of RmbA formed helical structures. In a study to describe the relationship between the primary structure and solubility of protein, the amino acids that were seen more in soluble proteins have a higher helix propensity (Idicula- Thomas and Balaji, 2007) . It was now obvious that the soluble expression of RmbA is due to the C-terminal helices in its structure.
When the protein sequence in C-terminal regions of RmbA was thoroughly examined, we noticed the presence of two amino acid sequences ( 314 ITGVRRVEASL 324 ) and ( 340 AHRLVLGDHS 349 ) which formed two helical structures separately in the C-terminal of RmbA model. The helices are held together by hydrogen bonds formed by the amino acids within the residues. Although all amino acids in both residues except for S323 participate in hydrogen bonds, we selected only those particular amino acids for mutation in DnmL which have different physical properties with the corresponding amino acids in the RmbA sequence. The amino acids L314, Q321, G340 and I344 in DnmL sequence were found in place of I314, E321, A340 and V344, respectively, in the RmbA sequence. Since the corresponding amino acids have similar physical properties, the above amino acids in the DnmL were not mutated. However, some amino acids in the RmbA residues were dissimilar with the amino acids at the corresponding position in the DnmL sequence. The consequence was further confirmed when we extended the sequence alignment of RmbA with several bacterial thymidylyltransferases. The six distinct amino acids (313S, 317V, 322A, 339S, 341H and 348H) of RmbA were also conserved in other thymidylyltransferases. Therefore, we substituted the particular amino acids (R313S, T317V, H322A, A339S, S341H and D348H) in DnmL to generate a mutated DnmL. As we expressed mutated dnmL in E.coli, the expressed protein was found to be soluble. It was now obvious that the amino acids substituted in mutated DnmL would enable the formation of C-terminal helical structures during the folding process when expressed in E.coli. This result suggested that the solubility of protein is related to protein folding or structure.
Over the previous year, considerable progress has been made in the application of recombinant DNA technology to protein engineering. In this study, we designed and modified the protein sequences simply by recombinant DNA technology to obtain soluble expression protein with or without the knowledge of 3D structure of protein. The comparative study of the highly homolog thymidylyltransferases led to a conclusion that the core of solubility of these proteins lied on the C-terminal regions. From the experiments, it was also deduced that the solubility of protein depends upon the protein structure. Thus, this study will impart a clear insight into the relationship between the protein structure and solubility for protein engineering. Although all types of molecular interaction are important, this study concludes that the hydrophobicity is the dominant driving force for protein proper folding and hence the solubility. Hence, the overall method might be useful for improving solubility of proteins or converting an insoluble protein into a soluble one, which in turn facilitates the characterization of the protein. In conclusion, the sequence of amino acids determines the conformation of the protein and this in turn determines the solubility of the protein.
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